CVDPREVENT: A national primary care audit to support professionally led quality improvement (NOTICE TO PRACTICES: 1st December 2020)
We are happy to announce that GP practices are now invited to participate in CVDPREVENT. Practices should have received the Data Provision Notice outlining the collection, and further information can be found on the CVDPREVENT web page.
The new national audit will automatically extract routinely held GP data without any additional burden to practices. The first extraction will take place in December with the first reports anticipated in the summer 2021. 79% of practices in England have now agreed to participate.
(see also the Proactive Care page for general advice on managing LTCs)
- Covid-19 Resources from the Primary Care Cardiovascular Society including a practical guide to CVD prevention during the Covid-19 pandemic
- Learning bites from Primary Care Cardiovascular Society for management during COVID-19 pandemic including: Switch from warfarin to DOAC, Hypertension, Diabetes, Heart Failure
Webinar on Structured Medicine Review for patients with heart failure and hypertension
ACEi/ARBs in Covid
- ACE-inhibitor and ARB use during the Covid-19 outbreak – Position Statement from King’s Health Partners
Summary: King’s Health Partners cardiovascular department strongly recommends that all patient using ACE-i/ARB for hypertension, post MI LV dysfunction, hypertension, ischaemic heart disease, and heart failure with reduced ejection fraction should continue treatment with their usual therapy during the COVID-19 outbreak.
- NICE Rapid Evidence Summary on ACEs and ARBs in people with or at risk of Covid-19
- Public article from the British Heart Foundation about ACE inhibitors, ARBs and the links with coronavirus
- Advice for patients taking ACEi/ARBs and COVID
Direct-Oral Anticoagulants (DOACs)
Heart Failure Management
- Southwark: Clinical Effectiveness Southwark’s (CES) Guide for Heart Failure .
- Heart Failure management remains largely the same during Covid, but please remember that it is a risk factor for worse outcomes for Covid patients, so patients’ HF management should be proactively optimised when possible.
Patient information for Heart Disease and Heart Failure
- Patient information: Coronavirus and heart disease (British Heart Foundation)
- Patient information: Living with HF during Covid (Pumping Marvellous Foundation – the UK’s heart failure patient-led charity)